CorVel Co. (NASDAQ:CRVL – Get Free Report) insider Maxim Shishin sold 8,075 shares of the firm’s stock in a transaction that occurred on Monday, August 12th. The shares were sold at an average price of $299.85, for a total transaction of $2,421,288.75. Following the completion of the transaction, the insider now directly owns 1,600 shares of the company’s stock, valued at approximately $479,760. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.
CorVel Stock Performance
NASDAQ CRVL opened at $316.81 on Friday. CorVel Co. has a one year low of $187.92 and a one year high of $321.46. The firm has a 50 day simple moving average of $272.89 and a 200-day simple moving average of $256.09. The firm has a market cap of $5.44 billion, a price-to-earnings ratio of 72.00 and a beta of 1.08.
CorVel (NASDAQ:CRVL – Get Free Report) last issued its quarterly earnings results on Tuesday, July 30th. The business services provider reported $1.25 earnings per share (EPS) for the quarter. CorVel had a net margin of 9.55% and a return on equity of 33.26%. The company had revenue of $211.72 million during the quarter.
Institutional Inflows and Outflows
Wall Street Analyst Weigh In
Separately, StockNews.com lowered shares of CorVel from a “buy” rating to a “hold” rating in a research note on Tuesday.
Get Our Latest Research Report on CRVL
About CorVel
CorVel Corporation provides workers’ compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.
Further Reading
- Five stocks we like better than CorVel
- What Are Dividend Contenders? Investing in Dividend Contenders
- Michael Burry’s Alibaba Bet and the Broader Market Implications
- How Technical Indicators Can Help You Find Oversold StocksÂ
- Jeff Brown’s Exegesis AI Stock Picks
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Warren Buffett’s Bet: Why Berkshire Hathaway Bought Ulta Stock
Receive News & Ratings for CorVel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CorVel and related companies with MarketBeat.com's FREE daily email newsletter.